Ayla UZUN ÇİÇEK, Gaffari TUNÇ, Fatih KILIÇBAY

Risk of autism spectrum disorder in children with a history of hospitalization for neonatal jaundice

Background/aim: Limited research has focused explicitly on the association between neonatal jaundice and autism spectrum disorder (ASD), and inconclusive evidence exists in the literature within this framework. This study aimed specifically to investigate whether neonatal jaundice is a potential risk factor for ASD and whether there is a connection between the types of neonatal jaundice and the severity of ASD. Materials and method: This study involved 119 children with ASD [90 males (75.6%), 29 females (24.4%), mean age: 45.39 ± 11.29 months] and 133 healthy controls [100 males (75.2%), 33 females (24.8%), mean age: 46.92 ± 11.42 months]. Psychiatric disorders were diagnosed through the Diagnostic and Statistical Manual of Mental Disorders criteria. Childhood Autism Rating Scale (CARS) was used to assess the screening and diagnosis of autism. A specially prepared personal information sheet was employed to investigate sociodemographic characteristics and birth and clinical histories. Results: The rate of the history of jaundice and pathological jaundice requiring hospitalization and phototherapy were significantly higher in the ASD group compared to the controls. CARS total score and the mean scores of nearly all items were statistically higher in children with a history of pathological jaundice than those with a history of physiological jaundice. Conclusion: Neonatal jaundice, depends on its severity, seems to be one of the possible biological factors associated with subsequent development of and the severity of ASD. Establishing a causal relationship between neonatal jaundice and ASD by more comprehensive studies may contribute to alleviating of the severity of ASD for individuals at risk.Key words: Newborn, autism spectrum disorder, neonatal jaundice, phototherapy

PDF

___

1. American Psychiatric Association. DSM-5 Diagnostic Classification. Diagnostic and statistical Manual Of Mental Disorders. 5th ed. Washington,DC, USA: American Psychiatric Association Publishing 2013.
2. Çiçek AU, Akdag E, Erdivanli OC. Sociodemographic characteristics associated with speech and language delay and disorders. Journal of Nervous and Mental Disease 2020; 208 (2): 143-146. doi: 10.1097/NMD.0000000000001120
3. Bölte S, Girdler S, Marschik PB. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cellular and Molecular Life Sciences 2019; 76 (7): 1275- 1297. doi: 10.1007/s00018-018-2988-4
4. Wang C, Geng H, Liu W, Zhang G. Prenatal, perinatal, and postnatal factors associated with autism: A meta-analysis. Medicine 2017; 96 (18): e6696. doi:10.1097/MD.0000000000006696
5. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C et al. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics 2009; 123 (2) : 524- 532. doi: 10.1542/peds.2007-2915
6. Kujabi ML, Petersen JP, Pedersen MV, Parner ET, Henriksen TB. Neonatal jaundice and autism spectrum disorder: a systematic review and meta-analysis. Pediatric Research 2021; 1-16. doi: 10.1038/s41390-020-01272-x
7. Çoban A, Türkmen MK, Gürsoy T. Turkish neonatal society guideline to the approach, follow-up, and treatment of neonatal jaundice. Turkish Archives of Pediatrics 2018; 53 (1): 172-179. doi: 10.5152/TurkPediatriArs.2018.01816
8. Bhutani VK, Johnson-Hamerman L. The clinical syndrome of bilirubin-induced neurologic dysfunction. Seminars in Fetal & Neonatal Medicine 2015; 20 (1): 6-13. doi: 10.1016/j. siny.2014.12.008
9. Amin SB, Smith T, Timler G. Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders. Pediatric Research 2019; 85 (2): 191-197. doi: 10.1038/ s41390-018-0216-4
10. Brites D. Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights. Seminars in Perinatology 2011; 35 (3): 114-120. doi:10.1053/j.semperi. 2011.02.004
11. Johnson L, Bhutani VK. The clinical syndrome of bilirubininduced neurologic dysfunction. Seminars in Perinatology 2011; 35 (3): 101-113. doi: 10.1053/j.semperi.2011.02.003
12. Maimburg RD, Bech BH, Vaeth M, Møller-Madsen B, Olsen J. Neonatal jaundice, autism, and other disorders of psychological development. Pediatrics 2010; 126 (5): 872-878. doi: 10.1542/ peds.2010-0052
13. Maimburg RD, Vaeth M, Schendel DE, Bech BH, Olsen J et al. Neonatal jaundice: a risk factor for infantile autism? Paediatric and Perinatal Epidemiology 2008; 22 (6): 562-568. doi: 10.1111/j.1365-3016.2008.00973.x
14. Duan G, Yao M, Ma Y, Zhang W. Perinatal and background risk factors for childhood autism in central China. Psychiatry Research 2014; 220 (1-2): 410-417. doi: 10.1016/j. psychres.2014.05.057
15. Lozada LE, Nylund CM, Gorman GH, Hisle-Gorman E, ErdieLalena CR et al. Association of autism spectrum disorders with neonatal hyperbilirubinemia. Global Pediatric Health 2015; 2: 1-5. doi: 10.1177/2333794X15596518
16. Jenabi E, Bashirian S, Khazaei S. Association between neonatal jaundice and autism spectrum disorders among children: a meta-analysis. Clinical and Experimental Pediatrics 2020; 63 (1): 8-13. doi: 10.3345/kjp.2019.00815
17. Amin SB, Smith T, Wang H. Is neonatal jaundice associated with autism spectrum disorders: A systematic review. Journal of Autism and Developmental Disorders 2011; 41 (11): 1455– 1463. doi: 10.1007/s10803-010-1169-6
18. Bhattarai A, KC N, Subedi N, KC N, Bijukchhe SM et al. Prenatal and perinatal risk factors for autism at national children’s hospital. Journal of Gandaki Medical College-Nepal 2018; 11 (2): 67-73. doi:10.3126/jgmcn.v11i02.22987
19. Croen LA, Yoshida CK, Odouli R, Newman TB. Neonatal hyperbilirubinemia and risk of autism spectrum disorders. Pediatrics 2005; 115 (2): e135-138. doi: 10.1542/peds.2004- 1870
20. Froehlich-Santino W, Londono Tobon A, Cleveland S, Torres A, Phillips J et al. Prenatal and perinatal risk factors in a twin study of autism spectrum disorders. Journal of Psychiatric Research 2014; 54: 100-108. doi: 10.1016/j.jpsychires.2014.03.019
21. Wu YW, Kuzniewicz MW, Croen L, Walsh EM, McCulloch CE et al. Risk of autism associated with hyperbilirubinemia and phototherapy. Pediatrics 2016; 138 (4): e20161813. doi: 10.1542/peds.2016-1813
22. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). Journal of Autism and Developmental Disorders 1980; 10 (1): 91-103. doi: 10.1007/BF02408436
23. Sucuoğlu B, Öktem F, Akkök F, Gökler B. A Study about childhood autism scales. Journal Psychiatry Psychology Psychopharmacology 1996; 4 (2): 116-121.
24. Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D et al. Gene×Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Frontiers in Psychiatry 2014; 5: 53. doi: 10.3389/fpsyt.2014.00053
25. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B et al. Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry 2011; 68 (11): 1095-1102. doi: 10.1001/archgenpsychiatry.2011.76
26. Hisle-Gorman E, Susi A, Stokes T, Gorman G, Erdie-Lalena C et al. Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder. Pediatric Research 2018; 84 (2): 190-198. doi: 10.1038/pr.2018.23
27. Mamidala MP, Polinedi A, P.T.V PK, Rajesh N, Vallamkonda R et al. Prenatal, perinatal and neonatal risk factors of autism spectrum disorder: a comprehensive epidemiological assessment from India. Research in Developmental Disabilities 2013; 34 (9): 3004-3013. doi: 10.1016/j.ridd.2013.06.019
28. Tsao PC, Yeh HL, Shiau YS, Chang YC, Chiang SH et al. Longterm neurodevelopmental outcomes of significant neonatal jaundice in Taiwan from 2000-2003: a nationwide, populationbased cohort study. Scientific Reports 2020; 10 (1): 11374. doi: 10.1038/s41598-020-68186-w
29. Buchmayer S, Johansson S, Johansson A, Hultman CM, Sparén P et al. Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics 2009; 124 (5): e817-825. doi: 10.1542/peds.2008-3582
30. Cordero C, Schieve LA, Croen LA, Engel SM, Siega-Riz AM et al. Neonatal jaundice in association with autism spectrum disorder and developmental disorder. Journal of Perinatology 2020; 40 (2): 219-225. doi: 10.1038/s41372-019-0452-4
31. Zhang X, Lv CC, Tian J, Miao RJ, Xi W et al. Prenatal and perinatal risk factors for autism in China. Journal of Autism and Developmental Disorders 2010; 40 (11): 1311-1321. doi: 10.1007/s10803-010-0992-0
32. Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Frontiers in Cellular Neuroscience 2019; 13: 385. doi: 10.3389/fncel.2019.00385
33. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. International Journal of Developmental Neuroscience 2005; 23 (2-3): 183- 187. doi: 10.1016/j.ijdevneu.2004.09.006
34. Cheung C, Yu K, Fung G, Leung M, Wong C et al. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 2010; 5 (8): e12233. doi: 10.1371/journal.pone.0012233
35. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage- -mechanisms and management approaches. New England Journal of Medicine 2013; 369 (21): 2021-2030. doi: 10.1056/ NEJMra1308124
36. Wusthoff CJ, Loe IM. Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes. Seminars in Fetal & Neonatal Medicine 2015; 20 (1): 52-57. doi: 10.1016/j. siny.2014.12.003
37. Gathwala G, Sharma S. Oxidative stress, phototherapy and the neonate. Indian Journal of Pediatrics 2000; 67 (11): 805-808. doi: 10.1007/BF02726223
38. Sirota L, Straussberg R, Gurary N, Aloni D, Bessler H. Phototherapy for neonatal hyperbilirubinemia affects cytokine production by peripheral blood mononuclear cells. European Journal of Pediatrics 1999; 158 (11): 910-913. doi: 10.1007/ s004310051240
39. Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK et al. Jaundice, phototherapy and DNA damage in full-term neonates. Journal of Perinatology 2016; 36 (2): 132-136. doi: 10.1038/jp.2015.166
40. Besag FM. Epilepsy in patients with autism: links, risks and treatment challenges. Neuropsychiatric Disease and Treatment 2017; 14: 1-10. doi: 10.2147/NDT.S120509
41. Saemundsen E, Ludvigsson P, Hilmarsdottir I, Rafnsson V. Autism spectrum disorders in children with seizures in the first year of life - a population-based study. Epilepsia 2007; 48 (9): 1724-1730. doi: 10.1111/j.1528-1167.2007.01150.x
42. Ko C, Kim N, Kim E, Song DH, Cheon KA. The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder. Behavioral and Brain Functions 2016; 12 (1): 20. doi: 10.1186/s12993-016-0105-0
43. Tuchman R, Moshé SL, Rapin I. Convulsing toward the pathophysiology of autism. Brain & Development 2009; 31 (2): 95-103. doi: 10.1016/j.braindev.2008.09.009